Phase II study of TAK-875 in subject with diabetes
Phase 2
- Conditions
- Diabetes mellitus
- Registration Number
- JPRN-jRCT2080220872
- Lead Sponsor
- Takeda Pharmaceutical Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1.The subject is an out patient during screening
2.The subject signs a written informed consent form prior to the initiation of any study procedures, etc.
Exclusion Criteria
1.The subject with serious cardiac disease, cerebrovascular disorder, or any serious pancreatic or hematological disease, etc.
2.The subject who is considered ineligible to participate in the study by the investigator or subinvestigator, etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method